Corcept Therapeutics
CORT
#2169
Rank
S$11.08 B
Marketcap
S$105.22
Share price
-3.67%
Change (1 day)
52.32%
Change (1 year)

Earnings for Corcept Therapeutics (CORT)

Earnings in 2025 (TTM): S$86 Million

According to Corcept Therapeutics 's latest financial reports the company's current earnings are S$0.74 Billion. In 2024 the company made an earning of S$0.17 Billion, an increase over its 2023 earnings that were of S$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corcept Therapeutics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$86 M-51.06%
2024 S$0.17 B27.66%
2023 S$0.13 B-4.75%
2022 S$0.14 B-9.51%
2021 S$0.15 B-2.91%
2020 S$0.16 B14.87%
2019 S$0.14 B24.71%
2018 S$0.11 B69.32%
2017 S$67.82 M419.26%
2016 S$13.06 M-395.64%
2015 -S$4.42 Million-87.53%
2014 -S$35.45 Million-33.44%
2013 -S$53.26 Million
2011 -S$41.5 Million17.84%
2010 -S$35.22 Million35.5%
2009 -S$25.99 Million2.84%
2008 -S$25.27 Million60.81%
2007 -S$15.72 Million-52.14%
2006 -S$32.84 Million20.91%
2005 -S$27.16 Million31.87%
2004 -S$20.6 Million60.54%
2003 -S$12.83 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$41.57 B 49,305.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$10.30 B 12,150.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$21.07 B 24,939.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
S$28.87 B 34,218.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$15.20 B 17,974.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$29.63 B 35,113.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-S$35.22 Million-141.85%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
S$39.5 M-53.05%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$0.87 B 935.92%๐Ÿ‡บ๐Ÿ‡ธ USA